Information for current and prospective investors in Prescibe.
Our business
Prescibe operates a digital pharmacy platform serving patients directly. Revenue comes from dispensing prescription medicines and selling over-the-counter products, supplements, medical supplies and veterinary products.
Why this market
- Medicine costs drive people to skip or ration treatment, creating durable demand for transparent pricing
- Patients increasingly expect to manage health online, as they do banking
- Generic substitution offers substantial savings that a digital-first operator can pass on
- Regulatory barriers — licensing, accreditation, pharmacist supervision — favour operators who invest in compliance
How we approach risk
Pharmacy is regulated, and we treat compliance as core infrastructure rather than overhead: licensed pharmacist oversight of dispensing, verified supply chains, audited access to health data, and a documented refusal policy for orders we should not fill.
Financial information
We are not currently a public reporting company. Financial information is provided to qualified investors under confidentiality.
Contact
Email support@prescibe.com with 'Investor Relations' in the subject, including your firm and the nature of your interest.
Nothing on this page is an offer to sell or a solicitation to buy securities. Forward-looking statements involve risks and uncertainties, and actual results may differ materially.